225 related articles for article (PubMed ID: 28684865)
1. Dynamic relocalization of NHERF1 mediates chemotactic migration of ovarian cancer cells toward lysophosphatidic acid stimulation.
Oh YS; Heo K; Kim EK; Jang JH; Bae SS; Park JB; Kim YH; Song M; Kim SR; Ryu SH; Kim IH; Suh PG
Exp Mol Med; 2017 Jul; 49(7):e351. PubMed ID: 28684865
[TBL] [Abstract][Full Text] [Related]
2. Roles of NHERF1/EBP50 in cancer.
Georgescu MM; Morales FC; Molina JR; Hayashi Y
Curr Mol Med; 2008 Sep; 8(6):459-68. PubMed ID: 18781953
[TBL] [Abstract][Full Text] [Related]
3. NHERF1/EBP50 controls morphogenesis of 3D colonic glands by stabilizing PTEN and ezrin-radixin-moesin proteins at the apical membrane.
Georgescu MM; Cote G; Agarwal NK; White CL
Neoplasia; 2014 Apr; 16(4):365-74.e1-2. PubMed ID: 24862762
[TBL] [Abstract][Full Text] [Related]
4. Similar expression pattern of NHERF1 and EZRIN in papillary but not in solid areas of human serous ovarian carcinomas.
Demacopulo B; Lema BE; Cabrini RL; Kreimann EL
Acta Histochem; 2016 Oct; 118(8):797-805. PubMed ID: 27823775
[TBL] [Abstract][Full Text] [Related]
5. LPA-induced migration of ovarian cancer cells requires activation of ERM proteins via LPA
Park J; Jang JH; Oh S; Kim M; Shin C; Jeong M; Heo K; Park JB; Kim SR; Oh YS
Cell Signal; 2018 Apr; 44():138-147. PubMed ID: 29329782
[TBL] [Abstract][Full Text] [Related]
6. The cellular distribution of Na+/H+ exchanger regulatory factor 1 is determined by the PDZ-I domain and regulates the malignant progression of breast cancer.
Du G; Gu Y; Hao C; Yuan Z; He J; Jiang WG; Cheng S
Oncotarget; 2016 May; 7(20):29440-53. PubMed ID: 27097111
[TBL] [Abstract][Full Text] [Related]
7. Distribution dynamics and functional importance of NHERF1 in regulation of Mrp-2 trafficking in hepatocytes.
Karvar S; Suda J; Zhu L; Rockey DC
Am J Physiol Cell Physiol; 2014 Oct; 307(8):C727-37. PubMed ID: 25163515
[TBL] [Abstract][Full Text] [Related]
8. VIP regulates CFTR membrane expression and function in Calu-3 cells by increasing its interaction with NHERF1 and P-ERM in a VPAC1- and PKCĪµ-dependent manner.
Alshafie W; Chappe FG; Li M; Anini Y; Chappe VM
Am J Physiol Cell Physiol; 2014 Jul; 307(1):C107-19. PubMed ID: 24788249
[TBL] [Abstract][Full Text] [Related]
9. NHERF1/EBP50 controls lactation by establishing basal membrane polarity complexes with prolactin receptor.
Morales FC; Hayashi Y; van Pelt CS; Georgescu MM
Cell Death Dis; 2012 Sep; 3(9):e391. PubMed ID: 22992649
[TBL] [Abstract][Full Text] [Related]
10. NHERF1/EBP50 and NF2 as diagnostic markers for choroid plexus tumors.
Georgescu MM; Mobley BC; Orr BA; Shang P; Lehman NL; Zhu X; O'Neill TJ; Rajaram V; Hatanpaa KJ; Timmons CF; Raisanen JM
Acta Neuropathol Commun; 2016 May; 4(1):55. PubMed ID: 27229317
[TBL] [Abstract][Full Text] [Related]
11. Ezrin-radixin-moesin (ERM)-binding phosphoprotein 50 organizes ERM proteins at the apical membrane of polarized epithelia.
Morales FC; Takahashi Y; Kreimann EL; Georgescu MM
Proc Natl Acad Sci U S A; 2004 Dec; 101(51):17705-10. PubMed ID: 15591354
[TBL] [Abstract][Full Text] [Related]
12. NHERF1/EBP50 is a new marker in colorectal cancer.
Hayashi Y; Molina JR; Hamilton SR; Georgescu MM
Neoplasia; 2010 Dec; 12(12):1013-22. PubMed ID: 21170265
[TBL] [Abstract][Full Text] [Related]
13. The NHERF1 PDZ2 domain regulates PKA-RhoA-p38-mediated NHE1 activation and invasion in breast tumor cells.
Cardone RA; Bellizzi A; Busco G; Weinman EJ; Dell'Aquila ME; Casavola V; Azzariti A; Mangia A; Paradiso A; Reshkin SJ
Mol Biol Cell; 2007 May; 18(5):1768-80. PubMed ID: 17332506
[TBL] [Abstract][Full Text] [Related]
14. NHERF1 regulates the progression of colorectal cancer through the interplay with VEGFR2 pathway.
Gu Y; Yu H; Hao C; Martin TA; Hargest R; He J; Cheng S; Jiang WG
Oncotarget; 2017 Jan; 8(5):7753-7765. PubMed ID: 27999191
[TBL] [Abstract][Full Text] [Related]
15. NHERF2 protein mobility rate is determined by a unique C-terminal domain that is also necessary for its regulation of NHE3 protein in OK cells.
Yang J; Singh V; Cha B; Chen TE; Sarker R; Murtazina R; Jin S; Zachos NC; Patterson GH; Tse CM; Kovbasnjuk O; Li X; Donowitz M
J Biol Chem; 2013 Jun; 288(23):16960-16974. PubMed ID: 23612977
[TBL] [Abstract][Full Text] [Related]
16. Repressing of NHERF1 inhibits liver cancer progression by promoting the production of ROS.
Sun J; Li P; Yang J
Biochem Biophys Res Commun; 2019 Jan; 509(1):8-15. PubMed ID: 30581004
[TBL] [Abstract][Full Text] [Related]
17. NHE3 mobility in brush borders increases upon NHERF2-dependent stimulation by lyophosphatidic acid.
Cha B; Zhu XC; Chen W; Jones M; Ryoo S; Zachos NC; Chen TE; Lin R; Sarker R; Kenworthy AK; Tse M; Kovbasnjuk O; Donowitz M
J Cell Sci; 2010 Jul; 123(Pt 14):2434-43. PubMed ID: 20571054
[TBL] [Abstract][Full Text] [Related]
18. Dynamic Na+-H+ exchanger regulatory factor-1 association and dissociation regulate parathyroid hormone receptor trafficking at membrane microdomains.
Ardura JA; Wang B; Watkins SC; Vilardaga JP; Friedman PA
J Biol Chem; 2011 Oct; 286(40):35020-9. PubMed ID: 21832055
[TBL] [Abstract][Full Text] [Related]
19. NHERF1, a novel GPER associated protein, increases stability and activation of GPER in ER-positive breast cancer.
Meng R; Qin Q; Xiong Y; Wang Y; Zheng J; Zhao Y; Tao T; Wang Q; Liu H; Wang S; Jiang WG; He J
Oncotarget; 2016 Aug; 7(34):54983-54997. PubMed ID: 27448983
[TBL] [Abstract][Full Text] [Related]
20. A Novel NHERF1 Mutation in Human Breast Cancer and Effects on Malignant Progression.
Yang X; Du G; Yu Z; Si Y; Martin TA; He J; Cheng S; Jiang WG
Anticancer Res; 2017 Jan; 37(1):67-73. PubMed ID: 28011475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
